Propellon Therapeutics' Seed Round

Propellon Therapeutics raised a round of funding on March 22, 2017. Investors include Fight Against Cancer Innovation Trust.

Propellon Therapeutics is developing and commercializing novel cancer therapies targeting the WDR5 protein, essential for assembly of methyltransferase complexes and proper histone modification. The o…

Articles about Propellon Therapeutics' Seed Round: